Low Deceleration Capacity Is Linked to Higher Stroke Risk in Paroxysmal Atrial Fibrillation Patients
Atrial fibrillation (AF)—the most common heart rhythm disorder—affects millions worldwide and significantly raises the risk of stroke, heart failure, and early death. For patients with paroxysmal AF (AF that starts and stops on its own within 7 days), doctors rely on tools like the CHADS2 and CHA2DS2-VASc scores to estimate stroke risk. These scores use clinical factors (age, hypertension, diabetes, past stroke) to guide treatment, but they don’t capture how the cardiac autonomic nervous system—the body’s “control center” for heart rate and blood pressure—might influence risk.
A 2019 study by researchers at Nanchang University in China set out to fill that gap. They investigated whether deceleration capacity (DC)—a noninvasive marker of cardiac autonomic function—could predict stroke risk in patients with paroxysmal AF. Here’s what they found.
What Is Deceleration Capacity?
DC measures how well the heart slows down after periods of faster beating. It’s calculated from 24-hour Holter ECG recordings (portable heart monitors) using a method called phase-rectified signal averaging, which isolates subtle heart rate patterns. A normal DC is above 4.5 milliseconds (ms)—this means the parasympathetic nervous system (which calms the heart) is working properly. A DC below 4.5 ms signals autonomic dysfunction: the balance between the sympathetic (fight-or-flight) and parasympathetic (rest-and-digest) systems is off, which can disrupt heart and blood vessel function.
Study Design and Participants
The team analyzed data from 259 hospitalized patients with paroxysmal AF (no valvular heart disease) treated between August 2015 and June 2016. They excluded patients with missing Holter data, incomplete medical records, or non-sinus rhythm during monitoring.
Key details:
- 55% male, average age 66 years.
- DC was measured using a 12-lead Holter monitor and specialized software.
- Stroke risk was assessed with two standard tools:
- CHADS2: Scores 1 point for congestive heart failure, hypertension, age >75, diabetes; 2 points for past stroke/transient ischemic attack (TIA).
- CHA2DS2-VASc: Adds points for age 65–74, vascular disease, and female sex (more detailed than CHADS2).
Key Findings
The researchers split patients into two groups: normal DC (>4.5 ms, 188 patients) and abnormal DC (≤4.5 ms, 71 patients). Here’s what they discovered:
-
Abnormal DC is linked to major stroke risk factors
Patients with low DC were more likely to be older (average 70 vs. 65 years), have hypertension (62% vs. 48%), heart failure (49% vs. 33%), or a past stroke/TIA (27% vs. 10%). After adjusting for other factors, past stroke/TIA was the strongest independent predictor of abnormal DC (odds ratio: 2.86—meaning patients with a history of stroke/TIA were nearly 3x more likely to have low DC). -
Lower DC = higher stroke risk scores
The abnormal DC group had significantly higher CHADS2 and CHA2DS2-VASc scores—two of the most trusted tools for AF stroke risk. For example:- CHADS2: 2.25 (abnormal DC) vs. 1.40 (normal DC)
- CHA2DS2-VASc: 3.76 (abnormal DC) vs. 2.71 (normal DC)
The lower the DC, the higher the score: a negative correlation (r = -0.29 for CHADS2, r = -0.26 for CHA2DS2-VASc, both P < 0.001).
Why This Matters
DC reflects how well the autonomic nervous system regulates the heart. When DC is low, the system is imbalanced—sympathetic activity (which speeds the heart) may be too high, or parasympathetic activity (which slows it) too low. This imbalance can:
- Disrupt blood flow to the brain (by altering blood pressure or vessel stiffness).
- Increase inflammation and damage to blood vessels.
- Raise the risk of blood clots (a leading cause of stroke in AF).
For patients with paroxysmal AF, this study suggests DC could be a new tool to complement existing stroke risk scores. While CHADS2 and CHA2DS2-VASc focus on clinical history, DC adds a layer of biological data about how the heart’s “control system” is working.
Limitations to Consider
Like all studies, this one has caveats:
- Retrospective design: Data was pulled from medical records, so some details (long-term drug use, lifestyle factors) were missing.
- Single-center: Results may not apply to diverse populations.
- Small sample: Only 259 patients—larger, multi-center studies are needed to confirm findings.
The Takeaway
For patients with paroxysmal AF, low deceleration capacity is a red flag: it signals autonomic dysfunction and is strongly linked to higher stroke risk (as measured by standard scores). While more research is needed, DC could one day join CHADS2 and CHA2DS2-VASc as a key part of stroke risk assessment for AF.
If you or a loved one has paroxysmal AF, talk to your doctor about how tools like Holter monitoring (to measure DC) might fit into your care plan. Every piece of information helps reduce stroke risk—and save lives.
This study was conducted by Ying Ding, Zhen-Yan Xu, and colleagues from the Department of Cardiovascular Medicine and Jiangxi Key Laboratory of Molecular Medicine at Nanchang University. It was published in the Chinese Medical Journal (2019) and approved by the Second Affiliated Hospital of Nanchang University’s Ethics Committee. Funding came from the National Natural Science Foundation of China and Jiangxi Science Foundation.
doi:10.1097/CM9.0000000000000391
Was this helpful?
0 / 0